HVH-2930
HVH-2930 is a potent HSP90 inhibitor that reduces viability in both trastuzumab-sensitive and -resistant breast cancer cell lines by degrading key client proteins like HER2 and AKT. It demonstrates significant in vivo antitumor activity and favorable pharmacokinetics, supporting its use in oncology research for studying HSP90-dependent pathways and therapeutic resistance.
Product Specifications
CAS Number
3034605-72-3
Field of Research
Cardiovascular Research, Cell Biology, Metabolism Research, Signal Transduction
Smiles
O=C (NC=1C=CC=2C (=NN (C2C1) CCC3CCN (C) CC3) C) C4=CC=C5OC (C=CC5=C4OC) (C) C
Molecular Formula
C29H36N4O3
Molecular Weight
488.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
129248-Biotin 100 µL
LUM (Lumican, LDC, Keratan Sulfate Proteoglycan Lumican, KSPG Lumican, SLRR2D) (Biotin)
Sign In for Pricing
View Details 